| (USD) | Mar 2016 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, XTLB returned -44.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +13.2% |
| 1 year | -44.4% |
| 5 years | -86.7% |
| 10 years | -86.5% |
| All-time high | $1,928.00 (Sep 2005) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in XTLB would be worth today ›No. XTL Biopharmaceuticals Ltd. has not paid a dividend in the past 12 months.
XTL Biopharmaceuticals Ltd. stock trades on NASDAQ under the ticker symbol XTLB.
XTL Biopharmaceuticals Ltd. is part of the Healthcare sector.
XTL Biopharmaceuticals Ltd. has a market cap of 6.45M USD, based on the latest quote.
